Grant: Engage Grants Program
University of Ottawa
$23,000.00
Respiratory motion-correction for CO2-stress PET imaging
EF 2014-15
Résumé
Vascularix is a wholly-owned subsidiary of Thornhill Scientific lnc., a spin-off of Toronto's University Health Network. We are commercializing the RespirAct system, which controls gas concentrations in the lungs and blood, as a non-invasive, drug-free, stress agent for use in cardiac blood flow testing. Cardiac stress testing is performed to identify patients with heart disease, and to guide treatment. The RespirAct system has been used as a scientific tool for brain vascular assessment in over 500 clinical cases resulting in over 40 peer-reviewed publications primarily based on brain vascular reactivity. Vascularix is pursuing the commercialization of RespirAct for the cardiac stress test indication first, as the expected adoption and reimbursement landscape is more favorable than for the brain indications studied to date.A technical challenge for cardiac PET imaging however, is the effect of deep breathing during CO2-stress, that interferes with the accurate measurement of cardiac blood flow. The current project will develop methods to measure and correct for this respiratory motion artifact, and establish normal reference values in healthy volunteers.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
463679-2014
Name nom
deKemp, Robert
Department département
Electrical Engineering and Computer Science , School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
23000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Respiratory motion-correction for CO2-stress PET imaging
Keyword
NSERC
Application summary
Vascularix is a wholly-owned subsidiary of Thornhill Scientific lnc., a spin-off of Toronto's University Health Network. We are commercializing the RespirAct system, which controls gas concentrations in the lungs and blood, as a non-invasive, drug-free, stress agent for use in cardiac blood flow testing. Cardiac stress testing is performed to identify patients with heart disease, and to guide treatment. The RespirAct system has been used as a scientific tool for brain vascular assessment in over 500 clinical cases resulting in over 40 peer-reviewed publications primarily based on brain vascular reactivity. Vascularix is pursuing the commercialization of RespirAct for the cardiac stress test indication first, as the expected adoption and reimbursement landscape is more favorable than for the brain indications studied to date.A technical challenge for cardiac PET imaging however, is the effect of deep breathing during CO2-stress, that interferes with the accurate measurement of cardiac blood flow. The current project will develop methods to measure and correct for this respiratory motion artifact, and establish normal reference values in healthy volunteers.